Friday, March 17, 2023

SpectrumAi Finds $20M For Autism Treatment

Los Angeles-based SpectrumAi, a company that is developing software to help with measuring the effectiveness of autism therapy, has raised $20M in a series A funding round. The funding was led by CVS Health Ventures, and also included Cobalt Ventures, along with F-Prime, Frist Cressey and Autism Impact Fund. The company said it is developing analytics software which can is designed to improve data capture and objective measurement of applied behavior analysis (ABA) therapy for autism. Ling Shao is Founder & CEO of SpectrumAi.